Ellis Medicine
$0.0B Total AUM · Institutional LP profile covering 6 historical fund disclosure records ($18.2M parsed USD across disclosed rows) across disclosed strategy exposure in Multi-Strategy (investment geography mandates are evaluated separately from LP headquarters). 5 complete primary source trails are open below without registration.
Historical Fund Disclosures — Ellis Medicine
5 Open Source Trails (No Registration)Showing 5 open preview records out of 6 total tracked records (+1 gated pilot rows). Click Inspect Source on any row to view field-level substantiation, table headers/units, and archived page excerpts without login.
| Disclosed Fund / Vehicle | Strategy | Fund Vintage | Holding / Invested Value | Disclosed Performance | Primary Source Trail |
|---|---|---|---|---|---|
| Cif II US Investment Grade Intermed Institutional Trust Fund | Multi-Strategy | 2024 |
$6.6M Reported holding / fair value (not original commitment) · As of December 2024
|
Reported Holding / Fair Value · Not Yet Page-Verified | Inspect Source · DOL Form 5500 |
| US Inv Grade CORP Long Bond Institutional Trust Fund | Multi-Strategy | 2024 |
$6.6M Reported holding / fair value (not original commitment) · As of December 2024
|
Reported Holding / Fair Value · Not Yet Page-Verified | Inspect Source · DOL Form 5500 |
| Cif Global Research Equity Institutional Trust Fund | Multi-Strategy | 2024 |
$2.6M Reported holding / fair value (not original commitment) · As of December 2024
|
Reported Holding / Fair Value · Not Yet Page-Verified | Inspect Source · DOL Form 5500 |
| Cif II Select Leaders Portfolio | Multi-Strategy | 2024 |
$963K Reported holding / fair value (not original commitment) · As of December 2024
|
Reported Holding / Fair Value · Not Yet Page-Verified | Inspect Source · DOL Form 5500 |
| Cif Enduring Assets Portfolio | Multi-Strategy | 2024 |
$924K Reported holding / fair value (not original commitment) · As of December 2024
|
Reported Holding / Fair Value · Not Yet Page-Verified | Inspect Source · DOL Form 5500 |
Forward-Looking Searches, Pacing Plans & Governance Updates — Ellis Medicine
Tracked separately from historical commitments: active RFPs/searches, board pacing plans, leadership/CIO updates, and retained gatekeeper consultants.
Board-Approved Pacing Plans, Active RFPs & Target-vs-Actual Allocation Gap
Join waitlist for pacing dossier →
Retained Private Markets Advisors & Emerging-Manager Search Conduits
Join waitlist for consultant map →
CIO, Private Markets Officers & Official Pitch Intake Guidance
Join waitlist for team directory →
Request Pilot Access to Full Workspace Data for Ellis Medicine
You are viewing 5 open public preview records (out of 6 total tracked records for Ellis Medicine) with zero-registration primary source trails. Join the early-access waitlist to request pilot access:
- All 6 tracked historical disclosure records (+1 gated rows) & field-level provenance
- Disclosed fund performance & as-of reporting schedules
- Separated active searches, RFPs, approved FY2026 pacing plans & CIO governance updates
- Retained gatekeeper consultants (1), investment contacts (2) & CRM export
Join the Early-Access Waitlist
Enter your firm email to request pilot onboarding for Ellis Medicine and our interactive GP workspace.
Thank you for joining the Prilago early-access waitlist! We will reach out with pilot access details for your firm.
Strategies Disclosed by Ellis Medicine
Frequently Asked Questions: Ellis Medicine
What type of institutional allocator is Ellis Medicine and what is their typical disclosed ticket size?
Ellis Medicine is categorized under Healthcare / Hospital System (Regional Roadshow Hub: Schenectady, NY; Headquarters: Schenectady, NY). Across 6 historical disclosure records tracked on Prilago ($18.2M total parsed USD across disclosed rows), the median disclosed amount is $2.6M (range: $379K to $6.6M).
Which private-market strategies appear in Ellis Medicine's public disclosures?
Ellis Medicine has disclosed records across Multi-Strategy. Open preview records include Cif II US Investment Grade Intermed Institutional Trust Fund (2024 Vintage), US Inv Grade CORP Long Bond Institutional Trust Fund (2024 Vintage), Cif Global Research Equity Institutional Trust Fund (2024 Vintage), Cif II Select Leaders Portfolio (2024 Vintage).
How are Ellis Medicine's historical records substantiated and separated from active searches on Prilago?
Records for Ellis Medicine cite primary public disclosures (DOL Form 5500), and visitors can inspect 5 open source trails on this profile without registration. Each source trail displays field-level substantiation status, distinguishing exact commitment schedules from carrying-value or fee tables. Forward-looking active searches, RFPs, pacing plans, and governance updates are separated from historical disclosures.
How can General Partners request pilot access to Ellis Medicine's full commitment history and contacts?
General Partners can join the early-access waitlist on https://prilago.com/lp/ellis-medicine or test fund suitability in the interactive read-only demo at https://prilago.com/demo.